(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 12.70%134.66B | 18.04%84.79B | 30.97%44.6B | 83.70%159.93B | 70.31%119.49B | 75.98%71.83B | 58.61%34.06B | -14.35%87.06B | -10.62%70.16B | -20.86%40.82B |
Operating income | 12.70%134.66B | 18.04%84.79B | 30.97%44.6B | 83.70%159.93B | 70.31%119.49B | 75.98%71.83B | 58.61%34.06B | -14.35%87.06B | -10.62%70.16B | -20.86%40.82B |
Cost of sales | ---- | -20.01%-41.27B | ---- | -49.88%-76.8B | ---- | -47.99%-34.39B | ---- | -12.45%-51.24B | ---- | -2.38%-23.24B |
Operating expenses | -13.52%-120.74B | -20.01%-41.27B | -19.32%-39.73B | -49.88%-76.8B | -32.59%-106.36B | -47.99%-34.39B | -33.60%-33.29B | -12.45%-51.24B | -3.17%-80.22B | -2.38%-23.24B |
Gross profit | 6.00%13.92B | 16.23%43.52B | 540.74%4.88B | 132.09%83.13B | 230.63%13.14B | 112.97%37.44B | 122.06%761M | -36.12%35.82B | -1,446.05%-10.06B | -39.12%17.58B |
Selling expenses | -7.97%-5.17B | -10.69%-3.18B | -21.75%-1.62B | -45.79%-6.35B | -59.91%-4.79B | -59.73%-2.87B | -27.18%-1.33B | 7.44%-4.36B | 19.55%-3B | 21.89%-1.8B |
Administrative expenses | -9.99%-3.02B | -7.39%-2.06B | -14.79%-1B | -18.20%-4.15B | -11.77%-2.74B | -20.20%-1.92B | -14.74%-872M | 4.15%-3.51B | 7.36%-2.46B | 9.76%-1.6B |
Research and development expenses | -0.80%-380M | ---- | -17.54%-134M | ---- | -40.67%-377M | ---- | -29.55%-114M | ---- | 10.07%-268M | ---- |
Profit from asset sales | 33.33%332M | ---- | -50.63%79M | ---- | 67.11%249M | ---- | 344.44%160M | ---- | 44.66%149M | ---- |
Depreciation and amortization | ---- | -7.22%-13.94B | ---- | -11.95%-27.17B | ---- | -9.61%-13B | ---- | -0.10%-24.27B | ---- | 2.04%-11.86B |
Revaluation surplus | -64.98%201M | ---- | 247.62%73M | ---- | 250.00%574M | ---- | -12.50%21M | ---- | 276.34%164M | ---- |
-Changes in the fair value of other assets | -64.98%201M | ---- | 247.62%73M | ---- | 250.00%574M | ---- | -12.50%21M | ---- | 276.34%164M | ---- |
Impairment and provision | 71.43%-2M | --304M | ---- | 127.39%123M | -123.33%-7M | ---- | ---- | 82.71%-449M | 2,900.00%30M | ---- |
-Impairment of property, machinery and equipment | ---- | --304M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairment is provision | 71.43%-2M | ---- | ---- | 127.39%123M | -123.33%-7M | ---- | ---- | ---449M | 2,900.00%30M | ---- |
Special items of operating profit | -51.78%1.59B | -10.54%-20.14B | 5.43%913M | -55.29%-40.03B | 11.30%3.29B | -41.32%-18.22B | 40.36%866M | 16.30%-25.78B | 1.02%2.96B | 18.20%-12.89B |
Operating profit | -21.66%7.02B | 214.52%4.51B | 570.46%3.06B | 124.65%5.56B | 170.72%8.96B | 113.56%1.43B | 86.29%-650M | -127.03%-22.54B | -286.52%-12.67B | -245.57%-10.56B |
Financing income | ---- | -56.62%95M | ---- | -21.01%361M | ---- | -12.40%219M | ---- | -32.30%457M | ---- | -34.38%250M |
Financing cost | 19.34%-4.29B | 2.02%-2.91B | -88.37%-1.54B | 1.30%-5.93B | 37.24%-5.32B | 0.64%-2.97B | 29.93%-817M | 3.16%-6.01B | -127.32%-8.47B | 6.33%-2.99B |
Share of profits of associates | ---- | -7,433.33%-1.32B | ---- | -17,161.54%-2.24B | ---- | 200.00%18M | ---- | -244.44%-13M | ---- | -73.91%6M |
Share of profit from joint venture company | ---- | 1.08%282M | ---- | 79.61%546M | ---- | 86.00%279M | ---- | 12.18%304M | ---- | -3.23%150M |
Special items of earning before tax | 590.68%2.22B | 60.03%-297M | 0.00%64M | 104.99%187M | -39.36%322M | 62.53%-743M | 14.29%64M | -396.21%-3.75B | 40.85%531M | -437.24%-1.98B |
Earning before tax | 24.94%4.96B | 120.24%357M | 212.83%1.58B | 95.18%-1.52B | 119.24%3.97B | 88.34%-1.76B | 76.02%-1.4B | -126.82%-31.55B | -210.99%-20.61B | -196.61%-15.13B |
Tax | -6.19%-1.27B | -6.69%-765M | -1.87%-327M | 33.70%-1.44B | -148.34%-1.2B | -122.81%-717M | -124.47%-321M | -174.84%-2.17B | 62.02%2.47B | 177.25%3.14B |
After-tax profit from continuing operations | 33.03%3.69B | 83.56%-408M | 172.85%1.26B | 91.23%-2.96B | 115.27%2.77B | 79.30%-2.48B | 62.02%-1.72B | -206.06%-33.72B | -255.59%-18.14B | -202.14%-11.99B |
Earning after tax | 33.03%3.69B | 83.56%-408M | 172.85%1.26B | 91.23%-2.96B | 115.27%2.77B | 79.30%-2.48B | 62.02%-1.72B | -206.06%-33.72B | -255.59%-18.14B | -202.14%-11.99B |
Minority profit | 18.62%1.72B | 63.13%646M | 187.36%500M | 216.32%1.18B | 364.60%1.45B | 179.84%396M | 504.65%174M | -193.30%-1.02B | -153.78%-548M | -168.60%-496M |
Profit attributable to shareholders | 48.86%1.97B | 63.36%-1.05B | 139.83%756M | 87.34%-4.14B | 107.51%1.32B | 74.96%-2.88B | 57.78%-1.9B | -170.11%-32.7B | -187.42%-17.59B | -144.99%-11.49B |
Basic earnings per share | 57.14%0.11 | 62.50%-0.06 | 140.00%0.04 | 87.89%-0.23 | 106.80%0.07 | 76.47%-0.16 | 62.96%-0.1 | -153.33%-1.9 | -171.05%-1.03 | -126.67%-0.68 |
Diluted earnings per share | 120.00%0.11 | 62.50%-0.06 | 140.00%0.04 | 87.89%-0.23 | 104.85%0.05 | 76.47%-0.16 | 62.96%-0.1 | -153.33%-1.9 | -171.05%-1.03 | -126.67%-0.68 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | KPMG Huazhen (Special General Partnership), KPMG | -- | -- | -- | KPMG Huazhen (Special General Partnership), KPMG | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data